See all
...Jabbour, MD Disclosure: Serge Jabbour, MD, has disclosed that he has served on the speaker's bureau for Amylin and Eli Lilly. Rubin Minhas, MB, ChB Disclosure: Rubin Minhas, MB, ChB, has disclosed no relevant financial relationships. Matt Rosenberg,...
...test results and regulatory decisions made on a new type of one-a-day drug from Novo Nordisk and a once-a-week drug from Eli Lilly, Amylin Pharmaceuticals and Alkermes. GlaxoSmithKline could finally win FDA approval next year of its shot, Cervarix, for...
See All
Earlier this week
... Eli Lilly and Company (LLY) (JOBS) Pulls FDA 12/1/2008 INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY - News) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food...
...DELHI: U.S.-based pharma giant Eli Lilly and Company has filed a case against Aurobindo Pharma and Lupin, alleging infringement of patent of its anti-depressant drug Cymbalta. The drug, whose patent will expire on June 2013, has a total global sales of...
See All
...Nov. 25 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX - News) today announced that it has purchased from Eli Lilly & Company a reduction in certain royalty amounts that may become payable to Eli Lilly on net sales of TorreyPines'...
...person living with or treating diabetes inspire ours. For more information, visit http://www.lifeforachild.org. About Eli Lilly and Company Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and...
See All